Key facts
- This page summarizes Joseph Todisco's Form 4 filing for CorMedix Inc. (CRMD).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 16 Nov 2026, 07:30.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Additional SEC filing notes
Footnote F1
This transaction was executed in multiple trades at prices ranging from $4.85 to $5.00, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.